Clinical Trial Search

Primary: Change in Pain Scores Assessed Within the Numeric Rating Scale (NRS) Component of the Modified Harris Mucositis-related Pain Assessment Tool — 1.69; 5.2; 4.54; 5.15…

Primary: Clinical Oral Mucosal Injury Score at Cumulative Radiation Dose of 5000 cGy — 1.42; 1.36 units on a scale

Primary: Duration of Ulcerative Oral Mucositis — 2.3; 3.2 Days

Primary: Oral Mucositis Severity - WHO Scale — 3; 3; 0; 0 participants

Primary: Change in Pain Scores — 2 score on a scale

Primary: Change From Baseline in Cumulative Pain on the Visual Analogue Scale (VAS) at Postoperative Week 1 — 3.27; 4.35 score on a scale

Primary: Feasibility of Photo Biomodulation Therapy (PBM) in Reducing Oral Mucositis (OM) in Children and Adolescents at Risk for Grade 3 OM Undergoing an Allogeneic…

Primary: Incidence of Severe OM During Radiation Therapy in Subjects Receiving a Cumulative IMRT Dose of at Least 55 Gy — 15; 9; 10; 12 Participants

Primary: Incidence and / or Severity of Oral Mucositis — 19; 3 Grade 3-4 oral mucositis — p=0.05

Primary: Mean Area Under the Curve (AUC) of Total Pain Reduction — 11.6; 11.7; 8.7 units on a scale*time scale — p=0.02

Primary: Change in Quality of Life From Mucositis-related Pain Measured by the Patient-Reported Oral Mucositis Symptoms (PROMS) Scale From Baseline to Follow-up — 20.1; 29.1…

Primary: Total Pain Reduction (Mouth and Throat) — -9.1; -4.7 units on a scale — p=<0.001

Primary: Change in Pain Score — 1.167; 1.58 score on a scale — p=0.3198

Primary: Severity of Oral Mucositis — 27; 24; 0; 0 Participants — p=<0.05

Primary: Number of Participants With Adverse Events (AEs) — 2; 3; 0; 2 participants

Primary: The Number of Subjects Who Achieve at Least a 30 Percent Decrease in Pain From Baseline in VAS Pain Score Calculated From BPI Questionnaire. — 8 Participants

Primary: Maximum Change in Mean Mouth and Throat Soreness (MTS) Score From Baseline Through Weeks of Radiation Therapy Using the MTS Question of the Modified Oral Mucositis Daily…

Primary: Average/Cumulative Opioid Dose — 32.65306; 31.60714 mg

Primary: Pain Visual Analogue Scale (VAS) Score Measured at 10-point Scale — 7.4; 6.8; 6.0; 6.4 units on a scale — p=0.25

Primary: Incidence of Oral Mucositis — 66; 10; 64 percentage of participants

Primary: Number of Participants With Severe (Grade 3 or 4) Oral Mucositis — 62; 51; 29; 43 participants — p=0.0410

Primary: Severity of Mucositis According to the Radiation Therapy Oncology Group (RTOG) for Patients Who Had at Least One Mucositis Assessment — 14; 18 Participants

Primary: WHO (World Health Organisation) Oral Mucositis Severity Score During 28 Days of Treatment, Intention to Treat Population — 0.63; 0.56 score

Primary: Duration of Severe Oral Mucositis (SOM) — 12.5; 20.0 days — p=0.1798

Primary: Self-reported Pain Scores Using 100m Visual Analog Scale 0-100 Pain Score. — 6.4; 12.3 mm

Primary: Cumulative Radiation Dose at Which Severe Oral Mucositis (World Health Organization [WHO] Score ≥ 3) Was First Observed — 66; 56; 48; 60 Cumulative radiation dose (Gy)…

Primary: Number of Participants With Severe (Common Terminology Criteria for Adverse Events Version 4.0 [CTCAE v. 4.0] Grade 3-5 Oral Mucositis in Patients Treated to a…

Primary: Percentage of Participants With Severe (WHO Grade 3-4) Oral Mucositis — 23 percentage of participants

Primary: Duration (in Days) of Radiation Induced Severe Oral Mucositis (OM) Per World Health Organization (WHO) Criteria — 8; 1.5; 19 days

Primary: Number of Participants With Severe Oral Mucositis (WHO Grade 3 and 4) — 9; 6; 4; 9 participants